ArticlePharmacoEconomics2015

Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration.

Don Husereau et al.PubMed ↗Publisher ↗

No numbers read from the abstract.